Published in Clin Diagn Virol on October 01, 1996
HIV testing in a high-incidence population: is antibody testing alone good enough? Clin Infect Dis (2009) 2.23
Validation, performance under field conditions, and cost-effectiveness of Capillus HIV-1/HIV-2 and determine HIV-1/2 rapid human immunodeficiency virus antibody assays using sequential and parallel testing algorithms in Tanzania. J Clin Microbiol (2008) 1.94
Assessment of rapid tests for detection of human immunodeficiency virus-specific antibodies in recently infected individuals. J Clin Microbiol (2008) 1.26
Relative accuracy of serum, whole blood, and oral fluid HIV tests among Seattle men who have sex with men. J Clin Virol (2013) 1.14
HIV nucleic acid amplification testing versus rapid testing: it is worth the wait. Testing preferences of men who have sex with men. J Acquir Immune Defic Syndr (2012) 0.90
A simple whole-blood test for detecting antibodies to human immunodeficiency virus. Clin Diagn Lab Immunol (1998) 0.78
Utility of rapid antibody tests to exclude HIV-1 infection among infants and children aged <18 months in a low-resource setting. J Clin Virol (2012) 0.75
Application of the passive haemolysis test for the determination of rubella virus antibodies. Acta Pathol Microbiol Scand B (1975) 2.66
Pelvic inflammatory disease associated with Chlamydia trachomatis infection after therapeutic abortion. A prospective study. Br J Vener Dis (1983) 1.69
Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum. Scand J Gastroenterol (2003) 1.63
False-negative results of a ligase chain reaction assay to detect Chlamydia trachomatis due to inhibitors in urine. Eur J Clin Microbiol Infect Dis (1997) 1.61
Therapeutic abortion and Chlamydia trachomatis infection. Br J Vener Dis (1982) 1.53
Raised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infection. Liver (2002) 1.48
Second-generation anti-HCV tests predict infectivity. Vox Sang (1992) 1.43
Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up. Eur Addict Res (2002) 1.35
Diagnosis of recent Herpes simplex infections. A modified immunofluorescent test for the detection of specific Herpes simplex IgM antibodies after staphylococcal adsorption of IgG. Acta Pathol Microbiol Scand B Microbiol Immunol (1974) 1.33
The diagnostic value of determination of IgM antibodies against Mycoplasma pneumoniae by the indirect immunofluorescent antibody test. Acta Pathol Microbiol Scand B (1976) 1.29
Proliferative human T cell responses to Chlamydia trachomatis in vitro. Acta Pathol Microbiol Immunol Scand C (1983) 1.19
Beta-glucuronidase activity in the bile of gallstone patients both with and without duodenal diverticula. Scand J Gastroenterol (1989) 1.18
Sensitivity of western blotting (compared with ELISA and immunofluorescence) during seroconversion after HTLV-III infection. Lancet (1986) 1.17
Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies. Clin Diagn Lab Immunol (2000) 1.11
Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS. AIDS (1992) 1.04
Chlamydial serum IgG antibodies in patients with acute salpingitis measured by an enzyme-linked immunosorbent assay. Acta Pathol Microbiol Immunol Scand C (1982) 1.03
Effect of combined interferon-alpha induction therapy and ribavirin on chronic hepatitis C virus infection: a randomized multicentre study. Scand J Gastroenterol (2002) 1.02
Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia. QJM (1999) 0.97
An indirect immunofluorescent antibody test for determination of Rubella virus specific IgM antibodies. Elimination of secondary IgM rheumatoid factor staining after absorption of serum IgG with Staphylococcal protein A. Acta Pathol Microbiol Scand C (1978) 0.97
A rubella epidemic in an unvaccinated pregnant population. I. Screening methods and serological results. Scand J Infect Dis (1981) 0.97
A rotavirus staphylococcal co-agglutination test. Acta Pathol Microbiol Immunol Scand B (1983) 0.96
Relevance of a combined HIV antigen/antibody assay to detect early HIV infections in a low prevalence population: case reports. Clin Lab (2004) 0.96
An outbreak of hepatitis A among homosexuals linked to a family outbreak. Epidemiol Infect (2002) 0.93
Screening urine samples by leukocyte esterase test and ligase chain reaction for chlamydial infections among asymptomatic men. J Clin Microbiol (1995) 0.93
The duodenal bacterial flora in the region of papilla of Vater in patients with and without duodenal diverticula. Scand J Gastroenterol (1989) 0.91
Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group. Scand J Infect Dis (1997) 0.89
[Isolation and serological diagnosis of Chlamydia trachomatis in acute salpingitis]. Tidsskr Nor Laegeforen (1982) 0.88
T cell proliferative responses to Chlamydia trachomatis antigen in vitro in patients with a history of gynaecological chlamydia infection. Br J Vener Dis (1984) 0.88
Characterisation of an epidemic of hepatitis A virus involving intravenous drug abusers--infection by needle sharing? J Med Virol (1997) 0.87
The spectrum of hepatobiliary disease in primary hypogammaglobulinaemia. J Intern Med (1999) 0.86
Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group. Scand J Gastroenterol (1999) 0.85
Cell-mediated and humoral immune responses to chlamydial and herpesvirus antigens in patients with cervical carcinoma. Gynecol Oncol (1985) 0.83
Bacterial growth in the duodenum and in the bile of patients with gallstone disease treated with endoscopic papillotomy (EPT). Endoscopy (1986) 0.82
Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier. Transfusion (1990) 0.81
Characterization of Chlamydia trachomatis serotypes by human T-lymphocyte clones. Scand J Immunol (1985) 0.81
Detection of HBV DNA by PCR in serum from an HBsAg negative blood donor implicated in cases of post-transfusion hepatitis B. Arch Virol Suppl (1992) 0.80
Chlamydial secretory IgA antibodies in human milk. Acta Pathol Microbiol Immunol Scand C (1982) 0.79
The early introduction of HIV infection among Norwegians at highest risk. Scand J Infect Dis (1990) 0.79
Detection of adenovirus-specific immunoglobulin A in tears from patients with keratoconjunctivitis. Eur J Clin Microbiol (1986) 0.79
A unique hepatitis A virus strain caused an epidemic in Norway associated with intravenous drug abuse. The Hepatitis A Study Group. Scand J Infect Dis (1998) 0.79
Effect of interferon-alpha induction therapy on genotype 2b/3a and low viral load hepatitis C virus infection. A randomized multicentre study. Scand J Gastroenterol (2002) 0.79
Prevalence of anti-HCV in Norwegian blood donors with anti-HBc or increased ALT levels. Transfusion (1990) 0.78
[Hospital admissions due to obstructive lung diseases and pneumonia in two hospital districts]. Tidsskr Nor Laegeforen (1999) 0.78
Liver transplantation for endstage hepatitis C cirrhosis in a patient with primary hypogammaglobulinaemia. Scand J Infect Dis (1998) 0.78
Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot study. Scand J Gastroenterol (1997) 0.77
Varicose veins in developing countries. Lancet (1976) 0.77
[Surveillance of hepatitis A by molecular epidemiologic studies]. Tidsskr Nor Laegeforen (1999) 0.77
Beta-glucuronidase activity related to bacterial growth in common bile duct bile in gallstone patients. Scand J Gastroenterol (1988) 0.77
Risk of toxoplasmic encephalitis in AIDS patients: indications for prophylaxis. Scand J Infect Dis (1996) 0.77
Quantification of lipopolysaccharides in human bile with or without gram-negative bacteria. Scand J Gastroenterol (1992) 0.77
Reactivation of hepatitis B virus infection in an anti-HBc and anti-HBs positive patient after allogeneic bone marrow transplantation. Eur J Haematol (2000) 0.77
The significance of the carbohydrate constituents of bovine thrombin for the clotting activity. Biochim Biophys Acta (1971) 0.77
The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT Group. Scand J Gastroenterol (1998) 0.76
Beta-glucuronidase-producing bacteria in bile from the common bile duct in patients treated with endoscopic papillotomy for gallstone disease. Scand J Gastroenterol (1986) 0.76
Increasing incidence of Pneumocystis carinii pneumonia in renal transplant patients. Transplant Proc (1988) 0.75
Prevalence of cytomegalovirus antibodies in Norwegian kidney-transplant recipients and their living donors. A comparative study of two different methods. Acta Pathol Microbiol Immunol Scand B (1984) 0.75
[Electrophoresis of cerebrospinal fluid]. Nord Med (1971) 0.75
Acquired immunodeficiency syndrome (AIDS). Clinical, immunological, pathological, and microbiological studies of the first case diagnosed in Norway. Scand J Gastroenterol Suppl (1985) 0.75
[Mycoplasma hominis salpingitis. A serological study]. Tidsskr Nor Laegeforen (1985) 0.75
A rubella epidemic in an unvaccinated pregnant population. 2. Seroepidemiology. Scand J Infect Dis (1981) 0.75
[Hepatitis C virus among pregnant women in Norway--occurrence of antibodies and pregnancy outcome]. Tidsskr Nor Laegeforen (2000) 0.75
HIV infection in Norwegian haemophiliacs: the prevalence of antibodies against HIV in haemophiliacs treated with lyophilized cryoprecipitate from volunteer donors. Eur J Haematol (1987) 0.75
[Viral hepatitis and blood transfusion]. Tidsskr Nor Laegeforen (1991) 0.75
Effects of cloxacillin, doxycycline, fusidic acid and lincomycin on the mechanical properties of bone and skin in young rats. Acta Orthop Scand (1979) 0.75
[Granulocytopenia and infections during induction therapy of acute leukemia]. Tidsskr Nor Laegeforen (1981) 0.75
[HTLV examination of Norwegian blood donors]. Tidsskr Nor Laegeforen (1999) 0.75
Antibodies against BK virus in renal transplant recipient sera: results with five different methods indicate frequent reactivations. Scand J Infect Dis (1991) 0.75
Comparison of the in vitro activity of azlocillin and carbenicillin against 856 clinical bacterial isolates. NIPH Ann (1984) 0.75
[Chlamydia trachomatis. Direct detection with an immunofluorescence test]. Tidsskr Nor Laegeforen (1986) 0.75
[Anti-hepatitis C (HCV) ELISA. A serologic test for non-A non-B hepatitis (NANBH) after blood transfusion]. Tidsskr Nor Laegeforen (1989) 0.75
[Chronic hepatitis C. Experience with 50 patients]. Tidsskr Nor Laegeforen (1992) 0.75
Hysterosalpingography: value in estimating tubal function, and risk of infectious complications. Acta Eur Fertil (1985) 0.75
Infective, chronic carriers of hepatitis C virus among blood donors with no history of clinical hepatitis. Transfus Med (1991) 0.75
Early changes in peripheral blood T cell subsets induced by antiretroviral treatment of human immunodeficiency virus-1 positive individuals. Scand J Immunol (2000) 0.75
A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates. NIPH Ann (1979) 0.75
[Immunofluorescence test in the diagnosis of AIDS-associated virus infection in Norway]. Tidsskr Nor Laegeforen (1986) 0.75
Effects of oxytetracycline on the mechanical properties of bone and skin in young rats. Acta Orthop Scand (1978) 0.75
Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Construct Group. Scand J Infect Dis (1996) 0.75
[HIV testing of hospital patients]. Tidsskr Nor Laegeforen (1988) 0.75
HIV and hepatitis B infection in an international cohort of dental hygienists. Scand J Dent Res (1988) 0.75
Liposome encapsulation of the internal control for whole process quality assurance of nucleic acid amplification-based assays. J Microbiol Methods (2003) 0.75
Detection of GB virus C RNA by GBV-C LCx and two PCR assays with primers from the 5' non-coding and NS5B region. J Virol Methods (1998) 0.75
[Anti-HIV serology today. Specificity, sensitivity and predictive value]. Tidsskr Nor Laegeforen (1988) 0.75
[An outbreak of hepatitis A among intravenous drug addicts in Oslo 1995-96]. Tidsskr Nor Laegeforen (1997) 0.75